Fasken is delighted to be sponsoring and attending the Pharma & MedTech Compliance Conference, taking place from June 1-2, 2026, at the Omni King Edward Hotel in Toronto.
This annual event is the premier compliance and legal event for Canadian Pharma and MedTech professionals seeking updates from top industry thought leaders on regulatory developments and the latest strategies to navigate emerging risks.
A team of Fasken lawyers will be on site during the event to connect with leading compliance professionals working exclusively within life sciences compliance and legal departments.
About Fasken’s Life Sciences Team
Fasken’s team provides comprehensive support to life sciences clients throughout their lifecycle. Whether you’re a biotech startup, entering clinical trials, scaling up, expanding to new markets or exploring exit strategies, our team speaks your language. We know the unique challenges biotech and pharma companies face in securing and enforcing your patent portfolio, bringing a product to market, complying with Canada’s regulations, or raising funds across a competitive landscape. We have knowledgeable practitioners with advanced degrees in pharmaceutical sciences, clinical pharmacology, toxicology, and genetics. We know the sector.
Fasken lawyers and agents collaborate with our clients to provide advice tailored to your needs including marketing and product labelling, IP drafting and enforcement, competition, tax, litigation, contracts and agreements and a full range of corporate services from financings to M&A. Navigate complex challenges and bring your products to market in Canada with a team dedicated to your success. With a strong legal network in 47 countries, we also continue to be at the forefront of life sciences advancement and interests globally.
Fasken is ranked Band 1 by Chambers Canada for Life Sciences and is the most recognized Firm on The Globe & Mail’s list of Canada’s Best Law Firms 2025, being included in every category of Corporate Law and in Healthcare & Life Sciences and Intellectual Property.
For more information about Fasken’s Life Sciences Group, please contact Lina A. Lafortune at [email protected].
